Figures & data
Table 1. Patient cohorts providing plasma samples for analysis of DI
Table 2. Patients receiving AAT augmentation by intravenous infusion
Table 3. Patients receiving augmentation of AAT by aerosol administration
Figure 1. The effect of intravenous alpha-1 antitrypsin augmentation therapy on plasma levels of desmosine and isodesmosine (DI) in alpha-1 antitrypsin deficiency.
![Figure 1. The effect of intravenous alpha-1 antitrypsin augmentation therapy on plasma levels of desmosine and isodesmosine (DI) in alpha-1 antitrypsin deficiency.](/cms/asset/d51243bc-16ef-4c96-aa98-7cf96aea167b/icop_a_771163_f0001_b.gif)
Figure 2. The effect of intravenous alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in plasma.
![Figure 2. The effect of intravenous alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in plasma.](/cms/asset/9bb7bc5d-86e6-45fb-a8dc-22ad9390a3b6/icop_a_771163_f0002_b.gif)
Figure 3. The effect of Intravenous alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in bronchoalveolar lavage fluid.
![Figure 3. The effect of Intravenous alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in bronchoalveolar lavage fluid.](/cms/asset/2acce767-306d-4c6f-ad54-4543b6478ccf/icop_a_771163_f0003_b.gif)
Figure 4. The effect of aerosol alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in plasma.
![Figure 4. The effect of aerosol alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in plasma.](/cms/asset/97104d07-47de-49dc-a166-f1dbd5924296/icop_a_771163_f0004_b.gif)
Figure 5. The effect of aerosol alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in bronchoalveolar lavage fluid.
![Figure 5. The effect of aerosol alpha-1 antitrypsin augmentation therapy on levels of desmosine and isodesmosine (DI) in bronchoalveolar lavage fluid.](/cms/asset/d3380451-ff15-4e7a-a572-c105d88be43c/icop_a_771163_f0005_b.gif)